Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective

Abnormal accumulation of Tau protein is closely associated with neurodegeneration and cognitive impairment and it is a biomarker of neurodegeneration in the dementia field, especially in Alzheimer’s disease (AD); therefore, it is crucial to be able to assess the Tau deposits in vivo. Beyond the flui...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricci, Maria, Cimini, Andrea, Camedda, Riccardo, Chiaravalloti, Agostino, Schillaci, Orazio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657996/
https://www.ncbi.nlm.nih.gov/pubmed/34884804
http://dx.doi.org/10.3390/ijms222313002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657996/
https://www.ncbi.nlm.nih.gov/pubmed/34884804
http://dx.doi.org/10.3390/ijms222313002

Ejemplares similares